2 Hengstler J G,Bolt H M.Failure in drug development: The role of inhibition and induction of cytochrome P450 enzymes.Arch Toxicol,2008,82: 665-666
[2]
16 Shi L,Reid L H,Jones W D,et al.The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.Nat Biotechnol,2006,24: 1151-1161
[3]
19 Wang Z Y,Zhang H Y.Rational drug repositioning by medical genetics.Nat Biotechnol,2013,31: 1080-1082
[4]
20 Shi Y,Hu Z,Wu C,et al.A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1.Nat Genet,2011,43: 1215-1218
[5]
21 Lu X,Wang L,Chen S,et al.Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease.Nat Genet,2012,44: 890-894
[6]
22 Han J W,Zheng H F,Cui Y,et al.Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus.Nat Genet,2009,41:1234-1237
[7]
23 Wang F,Xu C Q,He Q,et al.Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population.Nat Genet,2011,43: 345-349
[8]
26 Lounkine E,Keiser M J,Whitebread S,et al.Large-scale prediction and testing of drug activity on side-effect targets.Nature,2012,486: 361-367
[9]
27 Yang L,Wang K,Chen J,et al.Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome— clozapine-induced agranulocytosis as a case study.PLoS Comput Biol,2011,7: e1002016
[10]
28 Yang L,Chen J,Shi L,et al.Identifying unexpected therapeutic targets via chemical-protein interactome.PLoS One,2010,5: e9568
[11]
30 Yang L,Chen J,He L.Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome.PLoS Comput Biol,2009,5: e1000441
[12]
34 Buse J B,Henry R R,Han J,et al.Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.Diabetes Care,2004,27: 2628-2635
[13]
35 Yang L,Agarwal P.Systematic drug repositioning based on clinical side-effects.PLoS One,2011,6: e28025
[14]
36 Cahill B C,O'Rourke M K,Strasburg K A,et al.Methotrexate for lung transplant recipients with steroid-resistant acute rejection.J Heart Lung Transplant,1996,15: 1130-1137
9 Zhang Y S.The development of biochemistry and molecular biology in China.IUBMB Life,2009,61: 549-554
[25]
10 Whittaker P A.What is the relevance of bioinformatics to pharmacology? Trends Pharmacol Sci,2003,24: 434-439
[26]
11 Hurle M R,Yang L,Xie Q,et al.Computational drug repositioning: From data to therapeutics.Clin Pharmacol Ther,2013,93: 335-341
[27]
12 Lamb J,Crawford E D,Peck D,et al.The Connectivity Map: Using gene-expression signatures to connect small molecules,genes,and disease.Science,2006,313: 1929-1935
[28]
13 Subramanian A,Tamayo P,Mootha V K,et al.Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles.Proc Natl Acad Sci USA,2005,102: 15545-15550
[29]
14 Kunkel S D,Suneja M,Ebert S M,et al.mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass.Cell Metab,2011,13: 627-638
[30]
15 Wen Z,Wang Z,Wang S,et al.Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map.PLoS One,2011,6: e18278
[31]
17 Shi L,Campbell G,Jones W D,et al.The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.Nat Biotechnol,2010,28: 827-838
[32]
18 Sanseau P,Agarwal P,Barnes M R,et al.Use of genome-wide association studies for drug repositioning.Nat Biotechnol,2012,30: 317-320
[33]
24 Kitchen D B,Decornez H,Furr J R,et al.Docking and scoring in virtual screening for drug discovery: Methods and applications.Nat Rev Drug Discov,2004,3: 935-949
[34]
25 Li H,Gao Z,Kang L,et al.TarFisDock: A web server for identifying drug targets with docking approach.Nucleic Acids Res,2006,34 (Web Server issue): W219-W224
[35]
29 Yang L,Luo H,Chen J,et al.SePreSA: A server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome.Nucleic Acids Res,2009,37 (Web Server issue): W406-W412
[36]
31 Ostrov D A,Grant B J,Pompeu Y A,et al.Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.Proc Natl Acad Sci USA,109: 9959-9964
[37]
32 Luo H,Chen J,Shi L,et al.DRAR-CPI: A server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome.Nucleic Acids Res,2011,39 (Web Server issue): W492-W498
[38]
33 Ghofrani H A,Osterloh I H,Grimminger F.Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond.Nat Rev Drug Discov,2006,5: 689-702
[39]
38 Huang J,Niu C,Green C D,et al.Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network.PLoS Comput Biol,2013,9: e1002998
[40]
39 Suthram S,Dudley J T,Chiang A P,et al.Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets.PLoS Comput Biol,2010,6: e1000662
[41]
40 Grubb S C,Maddatu T P,Bult C J,et al.Mouse phenome database.Nucleic Acids Res,2009,37 (Database issue): D720-D730
[42]
41 Wicks P,Vaughan T E,Massagli M P,et al.Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm.Nat Biotechnol,2011,29: 411-414
[43]
42 Jensen P B,Jensen L J,Brunak S.Mining electronic health records: Towards better research applications and clinical care.Nat Rev Genet,2012,13: 395-405
